Apidra 100IU Cartridge (3ml Each)
Marketer
Sanofi India Ltd
Salt Composition
Insulin Glulisine (100IU)
Overview Apidra 100IU Cartridge (3ml Each)
Insulin Glulisine 100 IU/ml (3ml Cartridge) is indicated for glycemic control in individuals with type 1 and type 2 diabetes. This rapid-acting insulin lowers postprandial glucose levels, mitigating the risk of diabetic complications. It's typically administered in conjunction with a longer-acting insulin or other antidiabetic agents. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. Injection should occur 15 minutes prior to, or within 20 minutes following, meal commencement. Discontinuation requires physician approval. Optimal management involves this medication, a balanced diet, regular physical activity, and weight management as directed. Regular blood glucose monitoring is crucial for dose adjustment; share results with your doctor. Common adverse effects include hypoglycemia, hypersensitivity reactions, injection site reactions, lipoatrophy/hypertrophy, pruritus, rash, and upper respiratory infections. Precise dosing, consistent meals, and diligent glucose monitoring help minimize these risks. Avoid use with existing hypoglycemia. Prior kidney, liver, or heart conditions should be disclosed to your physician before initiating therapy. Consult your doctor if you are pregnant or breastfeeding.
Uses of Apidra 100IU Cartridge (3ml Each)
High blood sugar
Major Benefits of Apidra 100IU Cartridge (3ml Each):
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Apidra 100IU Cartridge (3ml Each):
- Hypoglycemia (low blood glucose level)
- Allergic reaction
- Injection site reactions (pain, swelling, redness)
- Lipodystrophy (skin thickening or pits at the injection site)
- Itching
- Rash
- Upper respiratory tract infection
How to use Apidra 100IU Cartridge (3ml Each):
Your healthcare provider will instruct you on the proper administration of this medication.
How Apidra 100IU Cartridge (3ml Each) works:
Glulisine insulin (Apidra), supplied in 3ml cartridges (100 IU each), rapidly lowers blood glucose levels, typically within 10 to 20 minutes of injection. Its action mimics natural insulin, promoting glucose absorption by muscle and fat tissues while simultaneously inhibiting hepatic glucose production.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Apidra 100 IU cartridges (3ml each) poses a safety risk.
PregnancySAFE IF PRESCRIBED
Employing Apidra 100 IU cartridges (3 mL each) during pregnancy is typically deemed safe. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; however, clinical data from human studies are scarce.
Breast feedingCONSULT YOUR DOCTOR
Data on Apidra 100 IU cartridges (3ml) use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Apidra 100 IU cartridges (3 mL each). Dosage modifications for Apidra 100 IU cartridges (3 mL each) may be necessary. Physician consultation is advised. Consistent blood glucose monitoring is recommended to guide appropriate dosage changes.
LiverCAUTION
Individuals with hepatic impairment should use Apidra 100 IU cartridges (3 mL each) cautiously. Dosage modification of Apidra 100 IU cartridges (3 mL each) may be necessary. Physician consultation is recommended. Close, consistent monitoring of blood sugar is advisable.
What if you forget to take Apidra 100IU Cartridge (3ml Each) :
Failing to administer a scheduled dose of your Apidra 100IU Cartridge (3ml) may lead to elevated blood glucose (hyperglycemia). Monitor your blood sugar levels and adjust your subsequent injection accordingly.
Facts to Know About Apidra 100IU Cartridge (3ml Each)
| Label | Value |
|---|---|
| Chemical Classification | Modified insulin |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Fast-acting insulin analogs |






